CONCORDBIO
NSEConcord Biotech Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,353.80
10.50 (0.78%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹14.16K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
54.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹987+37.2%
52W High₹2,146-36.9%
Current Price
₹1,353.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,083.04
Upper Circuit₹1,624.56
Reference Price
₹1,353.80
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹979.8
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹1595.3
Trend: Price above all key MAs — strong uptrend
RSI at 71.0 — overbought, pullback risk
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
46%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1208.74
EMA50
1160.73
EMA200
1330.07
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows8
Lower Highs4
Lower Lows1
Support & Resistance Levels
Resistance (Above)
₹1382.45
₹1425.20
₹1455.00
₹1479.25
₹1518.45
Support (Below)
₹1334.20
₹1314.90
₹1291.30
₹1234.20
₹1113.60
Volume Analysis
TrendINCREASING
Change+801.80%
Unusual VolumeNo
Recent Price Gaps
Gap Up
3 days ago • 0.09%
BULLISH
Stop Loss Levels
Fixed Risk
1% Risk₹1340.26
3% Risk₹1313.19
5% Risk₹1286.11
7% Risk (Custom)
₹1259.03Technical Levels
1x ATR (Volatility)₹1294.71
2x ATR (Swing)₹1235.62
3x ATR (Trend)₹1176.53
Immediate Support₹1334.20
Moving Averages
EMA 9 (Short-term)₹1266.17
EMA 20 (Medium-term)₹1208.74
EMA 50 (Trend)₹1160.73
EMA 200 (Long-term)₹1330.07
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹409.6 Cr | ₹204 Cr | ₹247.1 Cr | ₹277.8 Cr |
| Net Profit | ₹140.4 Cr | ₹44.1 Cr | ₹63.1 Cr | ₹63.6 Cr |
| EPS | — | ₹4.21 | ₹6.03 | ₹6.08 |
| Operating Profit | ₹198.3 Cr | ₹76.6 Cr | ₹104.1 Cr | ₹105 Cr |
ROE
20.50%
ROCE
27.27%
Debt/Equity
0.00
Current Ratio
6.17
OPM
37.80%
NPM
22.91%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 03 Sept 2025 | Dividend - Rs 10.70 Per Share | DIVIDEND |
| 21 Jun 2024 | Dividend - Rs 8.75 Per Share | DIVIDEND |
| 21 Jun 2024 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CONCORDBIO
View AllNEWS
positive
Business Standard - Markets 1d ago
Concord Biotech completes ANVISA inspection at Limbasi API facility
Concord Biotech announced the successful completion of an inspection conducted by Brazil's National Health Surveillance Agency (ANVISA) at its active pharmaceutical ingredient (API) manufacturing facility in Limbasi.
CONCORDBIOMEDANTAHealthcare
positive
Business Standard - Markets 2d ago
Concord Biotech, Carysil among top stocks to buy today; check targets
Kunal Kamble, sr. technical research analyst at Bonanza, has recommended buying shares of Concord Biotech, Carysil, and Welspun Enterprises today
CARYSILCONCORDBIOWELCORPWELENTCapital GoodsConstruction
positive
Google News - India Markets 2d ago
Wipro Buyback Starts Today | Concord Biotech Gets USFDA Nod | Top Buzzing Stocks Today - Equitymaster
Wipro Buyback Starts Today | Concord Biotech Gets USFDA Nod | Top Buzzing Stocks TodayEquitymaster
CONCORDBIOWIPROHealthcareInformation Technology